Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 13,959 |
|
|||||
| News | (1) | ||||||
| Day High | 3.87 | Low High |
|||||
| Day Low | 3.64 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Nutriband Inc | NTRB | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.34 | -8.83% | 3.51 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 3.71 | 3.64 | 3.87 | 3.65 | 3.85 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 90 | 13,959 | $ 3.73 | $ 52,123 | - | 1.53 - 5.9274 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:20:14 | formt | 101 | $ 3.51 | USD |
Nutriband Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 28.59M | 7.83M | - | 2.08M | -4.48M | -0.57 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Nutriband News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical NTRB Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 4.18 | 4.39 | 3.20 | 3.77 | 20,224 | -0.67 | -16.03% |
| 1 Month | 4.25 | 5.9274 | 3.20 | 4.52 | 80,099 | -0.74 | -17.41% |
| 3 Months | 2.62 | 5.9274 | 2.22 | 3.94 | 47,571 | 0.89 | 33.97% |
| 6 Months | 2.14 | 5.9274 | 1.53 | 3.71 | 26,516 | 1.37 | 64.02% |
| 1 Year | 3.71 | 5.9274 | 1.53 | 3.50 | 29,682 | -0.20 | -5.39% |
| 3 Years | 5.48 | 12.32 | 1.53 | 9.18 | 436,887 | -1.97 | -35.95% |
| 5 Years | 5.48 | 12.32 | 1.53 | 9.18 | 436,887 | -1.97 | -35.95% |
Nutriband Description
| Nutriband Inc is primarily engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's lead product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products. |
